The production of viruses, whether for use as viral vaccines, viral vectors for gene therapy, or oncolytic applications, requires complex processes that can translate into high costs, as well as slow ...

The author reviews the state of downstream processing and considers potential solutions, including the streamlining of full processes and borrowed technologies. The biopharmaceutical industry relies ...

Enveloped viruses have tremendous potential in a number of areas of great interest to biotech and pharma firms including gene therapy and vaccination. These viruses, which are typically produced in ...

CMOs are working hard to improve performance by investigating new technologies for filtration and purification. Downstream processing problems are not unique to CMOs, of course. It seems, however, ...

Securecell has announced the introduction of Sephara, a high performance in-situ filtration membrane for applications in bioprocess sampling and perfusion processes for use in selected bioprocess ...

The Global Downstream Processing Industry, valued at USD 15.6 billion in 2023, is projected to experience robust growth at a CAGR of 12.6% from 2024 to 2034. By the end of the forecast period, it is ...